Biomedicine and Biotechnology
ISSN (Print): 2378-5527 ISSN (Online): 2378-5535 Website: Editor-in-chief: Apply for this position
Open Access
Journal Browser
Biomedicine and Biotechnology. 2014, 2(4), 85-92
DOI: 10.12691/bb-2-4-4
Open AccessArticle

Methotrexate-induced Hepatic and Renal Toxicity: Role of L-carnitine in Treatment

Ehab Tousson1, , Zaki Tawfeek Zaki2, Walid Ali Abu-Shaeir2 and Hamada Hassan2

1Zoology Department, Faculty of Science, Tanta University, Tanta 31527, Egypt

2Zoology Department, Faculty of Science, Alazhar University, Cairo, Egypt

Pub. Date: November 24, 2014

Cite this paper:
Ehab Tousson, Zaki Tawfeek Zaki, Walid Ali Abu-Shaeir and Hamada Hassan. Methotrexate-induced Hepatic and Renal Toxicity: Role of L-carnitine in Treatment. Biomedicine and Biotechnology. 2014; 2(4):85-92. doi: 10.12691/bb-2-4-4


Methotrexate (MTX) is used as a chemotherapeutic agent used to treat many cancer types. The present study aimed to examine the possible modifying effects of l-carnitine against hepatic and renal toxicity induced by MTX in rats. A total 60 male albino rats were equally divided into six groups; the first and second groups were the control and l-carnitine groups respectively while the 3rd group was MTX rat group; the 4th and 5th groups were co- and post treated MTX rat with l-carnitine respectively and the 6th group was MTX self treated rat group. A significant increase in serum ALT, AST, urea, creatinine, uric acids and MDA levels and significant decrease GSH, catalase and total protein in MTX and self healing groups when compared with control and l-carnitine groups. In contrast, MTX-treated with l-carnitine exhibited a significant decrease in serum ALT, AST, urea, creatinine, uric acids and MDA levels and significant increase GSH, catalase and when compared with total protein in MTX and self healing groups. Histopathological results supported the biochemical results and the ameliorating effect of l-carnitine on liver and kidney toxicities. L-carnitine possessed various protective mechanisms against MTX-induced liver and kidney toxicity throughout co- and post treatment. We can conclude that treatment with l-carnitine during the MTX chemotherapy has beneficial properties and can reduce the liver and kidney toxicity induced by MTX.

Methotrexate (MTX) L-carnitine Oxidative damage Antioxidants liver Kidney

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


Figure of 3


[1]  Tousson E, Hafez E, Zaki S, Gad A. P53, Bcl-2 and CD68 expression in response to amethopterin-induced lung injury and ameliorating role of L-carnitine. 2014; BIOPHA 3409 1-9.
[2]  Tousson E, Atteya Z, El-Atrash A, Jeweely OI. Abrogation by Ginkgo Byloba Leaf Extract on Hepatic and Renal Toxicity Induced by Methotrexate in Rats. Journal of Cancer Research and Treatment 2014; 2 (3): 44-51.
[3]  Mardini H, Record C. Detection assessment and monitoring of hepatic fibrosis: biochemistry or biopsy? Ann Clin Biochem 2005; 42 (6): 441-447.
[4]  Hersh EM, Wong VG, Handerson ES, Freireich EJ. Effects of methotrexate. Cancer 1966; 19 (4): 600-606.
[5]  Penalva Polo JC, Gomez Andres A, Vela P, Niveiro M. (2002): Acute liver failure in a patient with methotrexate therapy. Rev Esp Enferm Dig 2002; 94 (7): 440-441.
[6]  Gong Y, Gluud C. Methotrexate for primary biliary cirrhosis. Cochrane Database Syst Rev 2005; 20 (3): CD004385
[7]  West SG. Methotrexate hepatoxicity. Rheum. Dis Clin North Am 1997; 23: 883-915.
[8]  Yozai K, Shikata K, Sasaki M, Tone A, Ohga S. Usui H. Methotrexate prevents renal injury in experimental diabetic rats via anti-inflammatory actions. J Am Soc Nephrol 2005; 16: 3326-3338.
[9]  ALL C, Ertan B, Ergul BK, Bulent K. N-acetylcysteine ameliorates methotrexate-induced oxidative liver damage in rats. Med Sci Monit 2006; 12 (8): 247-248.
[10]  Ozogula B, Kisaoglua A, Turanb MI, Altunerc D, Senerd E, Cetine N. Ozturk C. The effect of mirtazapine on methotrexate-induced toxicity in rat liver. Science Asia 2013; 39: 336-356.
[11]  Cetin A, Kaynar L, Kocyigit I, Hacioglu SK, Saraymen R, Ozturk A, Chan ES, Montesinos MC, Fernandez P. Adenosine A (2A) receptors play a role in the pathogenesis of hepatic cirrhosis. Br J Pharmacol 2006; 148 (8): 1144-1155.
[12]  Hemeida AR, Omar MM. Curcumin Attenuates Methotraxate-Induced Hepatic Oxidative Damage in Rats. Journal of the Egyptian Nat Cancer Inst 2008; 20 (2): 141-148.
[13]  Vardi N, Parlakpinar H, Ates B, Cetin A, Otlu A. Anti apoptotic and antioxidant effects of beta-carotene against methotrexate-induced testicular injury. Fertil Steri 2009; 92: 2028-2033.
[14]  Iyyaswamy A, Rathinasamy S. Effect of chronic exposure to aspartame on oxidative stress in the brain of albino rats. J Biosci 2012; 37: 679-688.
[15]  Vanella A, Russo A, Acquaviva R, Campisi A, Di Giacomo C, Sorrenti V, et al. L-Propionyl-carnitine as superoxide scavenger, antioxidant, and DNA cleavage protector. Cell Biol Toxicol 2000; 16: 99-104.
[16]  Srinivas SR, Prasad PD, Umapathy NS, Ganapathy V, Shekhawat PS. Transport of butyryl-L-carnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB (0,+). Am J Physiol. Gastrointest. Liver Physiol 2007; 293: 1046-1053
[17]  Salama AF, Kasem SM, Tousson E. and Elsisy MK. Protective role of L-carnitine and vitamin E on the kidney of atherosclerotic rats. Biomedicine & Aging Pathology 2012; 2: 212-215.
[18]  Salama A, Kasem S, Tousson E. and Elsisy MK. (2013): L-carnitine and vitamin E alleviate reproductive toxicity caused by triton WR 1339 in male albino rats. Toxicology and Industrial Health 2013; DOI: 10.1177/0748233712472523.
[19]  Panneerselvam KS, Kumaran S. L-Carnitine and alpha-lipoic acid improves mitochondrial function during ageing process. Clin Nutr, 2006; 21: 48-60
[20]  Jurisicova A, Varmuza S. Casper RF. Programmed cell death and human embryo fragmentation. Mol Hum Reprod 1996; 2: 93-98.
[21]  Flanagan JL, Simmons PA, Vehige J, Willcox MDP, Garrett Q. Role of carnitine in disease. Nutrition & Metabolism 2010; 7: 30.
[22]  Cave MC, Huit RT, Frazier TH, Matheson PJ, Grrison RN, McClave SA. Obesity, inflammation and the potential application of pharmaconutrition. Nutr Clin Pract 2008; 23: 16-34.
[23]  Yildirim R, Yildirim A, Dane S, Aliyev E, Yigitoglu R. Dose-Dependent Protective Effect of L-Carnitine on Oxidative Stress in the Livers of Hyperthyroid. EAJM 2013; 45: 1-6.
[24]  Agarwal V., Chauhan S., Singh R., Sachev A. and D’Cruz S. (2005): Pancytopenia with the first dose of methotrexate in a patient with psoriatic. J. Indian Assoc., 13: 60-61.
[25]  Weinhandl ED, Rao M, Gilbertson DT, Collins AJ, Pereira BJ. Protective effect of intravenous levocarnitine on subsequent-month hospitalization among prevalent hemodialysis patients, 1998 to 2003. Am J Kidney Dis 2007; 50: 803-812.
[26]  Saluk-Juszczak J, Olas B, Wachowicz B, Glowacki R, Bald E. L-carnitine modulates blood platelet oxidative stress. Cell Biol Toxicol 2010; 26: 355-365.
[27]  Reitman S, Frankel SA. colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Amer J Clin Pathol 1957; 28: 56-63.
[28]  Bowers LD, Wong ET. Kinetic serum creatinine assays. II. A critical valuation and review. Clin Chem 1980; 26 (5): 555-561.
[29]  Patton C, Crouch S. Determination of serum urea. Anal Chem 1977; 49: 464-469.
[30]  Fossati P, Prencipe L, Berti G.Use of 3,5-dichloro-2-hydroxybenzensulfonic acid/ 4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clin Chem 1980; 26: 227-231.
[31]  Sakeran MI, Zidan N, Rehman H, Aziz AT, Saggu S. Abrogation by Trifolium alexandrinum root extract on hepatotoxicity induced by acetaminophen in rats. Redox Rep 2014; 19 (1): 26-33.
[32]  Mesbah L, Soraya B, Narimane S, Jean PF. Protective effect of flavonoides against the toxicity of vinblastine cyclophosphamide and paracetamol by inhibition of lipid- peroxidation and increase of liver glutathione. Haema 2004; 7: 59-67.
[33]  Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963; 61: 882-888.
[34]  Aebi H. Catalase in vitro. Methods in Enzymology 1984; 105: 121-126.
[35]  Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
[36]  Tsuyosh O, James KB. A simplified method of quantitating protein using the biuret and phenol reagents. Anal Biochem 1978; 86: 193-200.
[37]  Bancroft JD, Steven A. Theory and Practice of Histological Technique (3rd ed.) NY: Churdchill living stone. 1990; 42: 107-110.
[38]  Vardi N, Parlakpinar H, Ozturk F, Ates B, Gul M, Cetin A, Erdogan A, Otlu A. Potent protective effect of apricot and β-carotene on methotrexate induced intestinal oxidative damage in rats. Food and Chemical Toxicology. 2008; 46: 3015-3022.
[39]  Roenigk HH Jr, Auerbach R, Maibach HI, Weinstein GD. Methotrexate guidelines revised. J Am Acad Dermatol. 1982; 6: 145-155.
[40]  Baughman RP, Lower EE. A clinical approach to the use of methotrexate for sarcoidosis. Thorax 1999; 54: 742-746.
[41]  Cheng KKF. Association of plasma methotrexate, neutropenia, hepatic dysfunction, Nausea/vomiting, and oral mucositis in children with cancer. European J Cancer Care 2008; 17: 306-311.
[42]  Genestier L, Paillot R, Quemeneur L, Izeradjene K, Revillard JP. Mechanisms of action of methotrexate. Immunopharmacology. 2000; 47: 247-257.
[43]  Wielinga P, Hooijberg JH, Gunnarsdottir S. The human multidrug resistance protein MRP5 transports folates and can mediate cellular resistance against antifolates. Cancer Res 2005; 65: 4425-4430.
[44]  Walling J. From methotrexate to pemetrexed and beyond. A review of the pharmacodynamic and clinical properties of antifolates. Investigational New Drugs 2006; 24: 37-77.
[45]  Johovic N, Cevik H, Sehirli OA, Yegen BÇ, Şener G. Melatonin prevents methotrexate-induced hepatorenal oxidative injury in rats. Journal of Pineal Research 2003; 34: 282-287.
[46]  Maiti R, Jana D, Das UK, Ghosh D. Antidiabetic effect of aqueous effect of seed of Tamarindus indica in streptozotocininduced diabetic rats. J Ethnopharmacol. 2004; 92: 85-91.
[47]  Fu Y, Zheng S, Lin J, Ryerse J, Chen A. Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol Pharmacol, 2008; 73 (2): 399-409.
[48]  Vaghasiya J, Bhalodia Y, Rathod S. Drug induced hepatotoxicity: effect of polyherbal formulation. Phcog Mag 2009; 5: 232-237.
[49]  Vardi A, Bosviel R, Rabiau N, Adjakly M, Satih S, Dechelotte P. Soy phytoestrogens modify DNA methylation of GSTP1, RASSF1A, EPH2 and BRCA1 promoter in prostate cancer cells. In Vivo 2010; 24: 393-400.
[50]  European Food Safety Authority (EFSA). Scientific opinion on the safety and efficiency of L-carnitine and L-tartrate as feed additives for all animal species based on a dossier submitted by Lonza Benelux. EFSA Journal 2012; 10 (5): 2676.
[51]  Friedmann S, Fraenkel G. Reversible enzymatic acetylation of carnitine. Arch Biochem Biophys 1955; 59, 491-501.
[52]  Fritz IB, Marquis NR. The role of acylcarnitine esters and carnitine palmityltransferase in the transport of fatty acyl groups across mitochondrial membranes. Biochemistry 1965; 54: 1226-1233.
[53]  Liedtke AJ, Nellis SH, Whitesell LF, Mahar CQ. Heart and Circulatory Physiology 1982; 243: 691-697.
[54]  Shug AL. Protection from adriamycin-induced cardiomyopathy in rats. Zeitschrift für Kardiologie 1987; 76 (5): 46-52.
[55]  Pierpont ME. Carnitine and myocardial function. In: Carter AL (ed.), Current concepts in carnitine research. Boca Raton, FL: CRS Press 1992; 192-212.
[56]  Broderick TL, Quinney HS, Lopaschuk GD. L-carnitine increases glucose metabolism and mechanical function following ischaemia in diabetic rat heart. Cardiovasc Res 1995; 29: 373-378.
[57]  Neu H. Carnitin: Chemie, Funktion und klinische Bedeutung bei Herzerkrankungen (Kardiomyopathien) des Hundes-eine Literaturübersicht. Kleintierpraxis 1995; 3: 197-220.
[58]  Drotman R, Lawhan G. Serum enzymes are indications of chemical induced liver damage. Drug Chem Toxicol 1978; 1: 117-163.
[59]  Sagu S, Divekar HM, Gupta V, Sawhney RC, Banerje PK, Kumar R. Adaptogenic and safety evaluation of Seabuckthorn (Hipophae rhamnoides) leaf extract: a dose dependent study. Food and Chemical Toxicology 2007; 45: 609-617.
[60]  Kadikoylu G, Bolaman Z, Demir S, Balkaya M, Akalin N, Enli Y. The effects of desferrioxamine on cisplatininduced lipid peroxidation and the activities of antioxidant enzymes in rat kidneys. Hum Exp Toxicol 2004; 23: 29-34.
[61]  Klukowska L, Nadulska A, Dyba S. The influence of cisplatinum and goserelinum on the magnesium and calcium level in rat serum. Ann. Univ. Mariae Curie Sklodowska [Med] 2001; 56: 483-486.
[62]  Saad MF, Greco S, Osei K, Lewin AJ, Edwards C, Nunez M, Reinhardt RR. Ragaglitazar improves glycemic control and lipid profile in type 2 diabetic subjects: a 12-week, double-blind, placebo controlled dose-ranging study with an open pioglitazone arm Diabetes. 2004; 27: 1324-1329.
[63]  Thabrew M, Joice P. A comparative study of the efficacy of Pavetta indica and Osbeckia octanda in the treatment of liver dysfunction. Planta Med 1987; 53 (3): 239-241.
[64]  Kolli VK, Abraham P, Rabi S. Methotrexate-induced nitrosative stress may play acritical role in small intestinal damage in the rat. Archives of Toxicology. 2008; 82 (10): 763-770.
[65]  Cetiner M, Sener G, Sehirli AO, Eksioglu-Demiralp E, Ercan F, Sirvanci S, Gedik N, Akpulat S, Tecimer T, Yegen BC. Taurine protects against methotrexate-induced toxicity and inhibits leucocyte death. Toxicol Appl Pharmacol 2005: 209 (1): 39-50.
[66]  Jahovic N, Sener G, Cevic H, Ersoy Y, Arbak S, Yegen BC. Amelioration of methotrexate-induced enteritis by melatonin in rats. Cell Biochem Funct 2004; 22-28.
[67]  Ciralik H, Bulbuloglu E, Cetinkaya A, Kurutas EB, Celik M, Polat A. Effects of N acetylcysteine on methotrexate induced small intestinal damage in rats. The Mount Sinai Journal of Medicine 2006; 73: 1086-1092.
[68]  Sener G, Eksioglu-Demiralp E, Cetiner M, Ercan F, Yegen BC. Beta-glucan ameliorates methotrexate-induced oxidative organ injury via its antioxidant and immunomodulatory effects. Eur J Pharmacol 2006; 542 (33): 170-178.
[69]  Lone IA, Kaur G, Athar M, Alam MS. Protective effect of Rumex patientia (English Spinach) roots on ferric. Food Chem Toxicol 2007; 45: 1821-1829.
[70]  Prahalathan C, Selvakumar E, Varalakshmi P. Protective effect of lipoic acid on adriamycin-induced testicular toxicity. Clinica Chimica Acta, 2005; 360: 160-166.
[71]  O’Rourke RA, Eckert GE. Methotrexate-induced hepatic injury in an adult.A case report. Arch Int Med 1964; 113: 191-194.
[72]  Ros S, Juanol X, Condom E, Canas C, Riera J, Guardiola J, Del Blanco J, Rebasa P, Valverde J, Roig-Escofet O. Light and electron microscopic analysis of liver biopsy samples from rheumatoid arthritis patients receiving long-term methotrexate therapy. Scand J Rheumatol 2002; 31 (6): 330-336.
[73]  Hytiroglou P, Tobias H, Saxena R, Abramidou M, Papadimitriou CS, Theise ND. The canals of hering might represent a target of methotrexate hepatic toxicity. Am J Clin Pathol. 2004; 121 (3): 324-329.
[74]  Amin KA, Nagy MA. Effect of Carnitine and herbal mixture extract on obesity induced by high fat diet in rats. Diabetology & Metabolic Syndrome 2009; 1: 17.